Inrebic (fedratinib)

£6,398.86

Inrebic (fedratinib) is a medication used for the treatment of adult patients with intermediate-2 or high-risk primary or secondary (post-polycythemia vera or post-essential thrombocythemia) myelofibrosis.

This medicine is not (yet) part of our standard product range but we may be able to get it for you. The packaging size and strength below may vary due to product availability. Please contact us to verify price and availability.

DISEASE INDICATIONS

Myelofibrosis

MANUFACTURER

Impact Biomedicines, Inc.

USAGE

Oral

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

  • Food and Drug Administration (FDA)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

This content has been reviewed by a Medical Doctor.
INREBIC (FEDRATINIB) Package

120 capsules of 100 mg

Reviews

There are no reviews yet.

Be the first to review “Inrebic (fedratinib)”

Your email address will not be published. Required fields are marked *

Shopping Cart